Stay updated on PD-L1 Selected HNSCC Clinical Trial
Sign up to get notified when there's something new on the PD-L1 Selected HNSCC Clinical Trial page.
Latest updates to the PD-L1 Selected HNSCC Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference5%
- Check4 days agoNo Change Detected
- Check10 days agoChange DetectedA study on Pembrolizumab with or without Lenvatinib in a PD-L1 selected population for head and neck cancer showed results posted on 2024-07-16, replacing a previous study with results submitted on 2024-01-05.SummaryDifference2%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check24 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision or update to the content of the webpage.SummaryDifference0.3%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content or details of the webpage.SummaryDifference0.3%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to PD-L1 Selected HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1 Selected HNSCC Clinical Trial page.